655
Views
4
CrossRef citations to date
0
Altmetric
Guest Editorial

Mechanism of resistance to cetuximab therapy in colorectal cancer

Possible role of antibodies to immunoglobulin allotypes

Pages 553-554 | Published online: 23 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Janine Schuurman, Aran F. Labrijn & Paul W.H.I. Parren. (2012) Fab-arm exchange. mAbs 4:6, pages 636-636.
Read now

Articles from other publishers (3)

Janardan P. Pandey. (2020) Innate and Acquired Resistance to Anti-EGFR Therapy—Letter. Clinical Cancer Research 26:7, pages 1773-1773.
Crossref
Oleg V. Borisov, Melissa Alvarez, James A. Carroll & Paul W. Brown. 2015. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study 63 117 .
K. Perez, R. Walsh, K. Brilliant, L. Noble, E. Yakirevich, V. Breese, C. Jackson, D. Chatterjee, V. Pricolo, L. Roth, N. Shah, T. Cataldo, H. Safran, D. Hixson & P. Quesenberry. (2013) Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology. Experimental and Molecular Pathology 95:1, pages 74-82.
Crossref